equilliumbio.com - EQ Operating profit EBITDA
Equillium, Inc. faces risks related to dependency on partner payments and competition within the autoimmune pathology therapy market. Total EBITDA for the period on the GURU.Markets line chart reflects profit dynamics, where the indicator level stands at 0.00. The company's revenues are not subject to macro cycles, as they depend on biological factors. Meanwhile, patent agreements ensure scalability and flexible operating leverage.
Summary analytical data breakdowns for Equillium (EQ)
- current quotes and average value forecast:
- issuer market value details:
- book value of equity indicators:
- debt level and financial liquidity data:
- earnings and valuation multiples indicators:
EQ - Company Net Income|Expected Profit Equillium, Inc.|EQ - P/E Multiple|Market Cap to Projected Earnings Equillium Inc|EQ - Price/Earnings to Growth Multiple|EV/EBITDA Multiple Equillium|EQ - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months Equillium|EQ - Net earnings per share for the last 12 months|Year-over-year earnings per one share growth for the last 12 months equilliumbio.com|EQ - Earnings growth in current year|Consensus forecast of earnings per share growth for next year Equillium, Inc.
Fundamental company valuation:EQ (Equillium, Inc.)
This indicator captures the daily net cash flow from operating activities, reflecting the actual balance of market demand through the lens of operational efficiency. By analyzing the EBITDA financial metric on the GURU.Markets platform, an investor can assess the ability of Equillium, Inc. (EQ) to monetize the uniqueness of the drug itolizumab amid low demand elasticity for transplant rejection therapy.
Who Equillium, Inc. competes with
ARGX - Operating profit before deduction of amortization|BNTX: Operating profit before deduction of amortization|ABVX - Operating profit EBITDA|ADMA Biologics, Inc. (ADMA) - Profit before payment of interest, taxes and amortization|Operating profit before amortization PTGX|IMVT (Immunovant Corp) - Operating profit EBITDA|Profit before interest, taxes and amortization Kiniksa Corp KNSA|Operating profit EBITDA GRFS|ADPT - Profit before interest, taxes and amortization|Profit before payment of interest, taxes and amortization Celldex Therapeutics, Inc. CLDX|Operating profit before depreciation charges Aurinia Pharmaceuticals Inc|BCRX: Operating profit before deduction of amortization|VERA - Operating profit EBITDA|DNTH: Operating profit EBITDA|PHVS - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization AbCellera Biologics Inc.|Profit before payment of interest, taxes and amortization TRML|Profit before payment of interest, taxes and amortization Intrexon (PGEN)|Profit before payment of interest, taxes and amortization PHAR (Pharming Corp)|Operating profit EBITDA NKTR (Nektar Therapeutics)|Operating income before deduction of amortization upstreambio.com (UPB)|ZBIO: Operating profit before deduction of amortization|IMNM - Operating profit EBITDA|Gossamer Corp (GOSS) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization KalVista Corp|Operating profit before deduction of amortization SEPN|PVLA: Income before deduction of interest, taxes and amortization|Operating profit EBITDA SVRA|Operating income before deduction of amortization Rigel Pharma|Profit before payment of interest, taxes and amortization AnaptysBio Corp ANAB|ATXS: Operating profit before amortization|enGene Holdings Inc. - Operating profit EBITDA|RAPT Therapeutics Inc. (RAPT) - Operating profit before deduction of amortization|JBIO (aerovatetx.com) - Operating profit before deduction of amortization|ACRS - Operating income before deduction of amortization|KYTX (Kyverna) - Operating profit EBITDA|Profit before interest, taxes and amortization Tiziana Life Sciences, Ltd. TLSA|Profit before payment of interest, taxes and amortization Cabaletta Bio, Inc. (CABA)|ventyxbio.com (VTYX) - Operating profit before depreciation charges|Profit before payment of interest, taxes and amortization Theratechnologies THTX|AVTX (Avalo Therapeutics, Inc.) - Profit before deduction of interest, taxes, depreciation and amortization|Eledon - Operating profit EBITDA|Income before deduction of interest, taxes and amortization AGEN (Agenus, Inc)|CLYM: Operating profit EBITDA|Zura Bio Ltd (ZURA) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization aTyr Pharma|ADAG: Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization ImageneBio Inc (IMA)|Operating profit before deduction of amortization shattucklabs.com STTK|Operating profit EBITDA CNTB (Connect Biopharma Holdings Limited)|Operating profit EBITDA Immunic Therapeutics IMUX|ATRA: Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization IFRX (InflaRx N.V.)|XFOR: Operating profit EBITDA|ACET - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Celularity Inc|Operating profit before deduction of amortization inmunebio.com (INMB)|Profit before payment of interest, taxes and amortization Barinthus Biotherapeutics plc (BRNS)|Operating profit before deduction of amortization Kezar Life Sciences Inc. KZR|SAB Biotherapeutics, Inc - Operating profit before deduction of amortization|Operating profit EBITDA Akari Therapeutics, Plc AKTX|ENLV - Profit before payment of interest, taxes and amortization|QTTB (Q32 Bio Inc.) - Operating profit before amortization|GOVX: Operating profit EBITDA|Profit before interest, taxes and amortization Edesa Biotech Inc (EDSA)|IBIO (iBio Corp) - Operating profit EBITDA|Profit before interest, taxes and amortization Carisma Tx CARM|Profit before payment of interest, taxes and amortization XTL Biopharmaceuticals (XTLB)|boltbio.com (BOLT) - Operating profit before depreciation charges|HCW Biologics - Operating profit before deduction of amortization|Operating profit EBITDA Aptevo Therapeutics, Inc. APVO|AIM ImmunoTech Inc. - Operating profit EBITDA|Operating income before deduction of amortization Aditxt ADTX|GRI Bio, Inc. (GRI) - Profit before payment of interest, taxes and amortization|XRTX (xortx.com) - Profit before payment of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Vyome Holdings|Profit before payment of interest, taxes and amortization REVB|Operating profit EBITDA INDP|Operating income before deduction of amortization BiondVax Pharmaceuticals|CalciMedica - Operating profit before deduction of amortization|Operating profit EBITDA Affimed NV AFMD|ALLK - Profit before payment of interest, taxes and amortization|HOOKIPA Pharma Inc. (HOOK) - Operating profit before deduction of amortization|IGMS (igmbio.com) - Operating profit before deduction of amortization|iTeos Pharma - Income before deduction of interest, taxes and amortization|OCEA (Ocean Biomedical, Inc.) - Operating profit EBITDA|tcbiopharm.com (TCBP) - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Third Harmonic Bio, Inc. (THRD)
